Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Greiner

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Bladder Cancer (Amsterdam, Netherlands)|November 13, 2018
Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder CancerMolly A Ingersoll, Xue Li, Brant A Inman, et al.
Cancer Research|May 20, 2004
Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN miceHasan E Zeytin, Arti C Patel, Connie J Rogers, et al.
Vaccine|August 19, 2008
Exercise enhances vaccine-induced antigen-specific T cell responsesConnie J Rogers, David A Zaharoff, Kenneth W Hance, et al.
Oncotarget|April 1, 2014
The immunocytokine NHS-IL12 as a potential cancer therapeuticJonathan Fallon, Robert Tighe, Giorgio Kradjian, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2014
Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasisJo A Tucker, Caroline Jochems, Benjamin Boyerinas, et al.
The Journal of Nutrition|December 25, 2007
Energy restriction and exercise differentially enhance components of systemic and mucosal immunity in miceConnie J Rogers, David Berrigan, David A Zaharoff, et al.
Cancer Research|September 5, 2002
Carcinoembryonic antigen as a target for specific antitumor immunotherapy of head and neck cancerErik S Kass, John W Greiner, Judith A Kantor, et al.
Advances in Cancer Research|June 4, 2014
Therapeutic cancer vaccinesJeffrey Schlom, James W Hodge, Claudia Palena, et al.
Frontiers in Oncology|May 7, 2020
The Use of a Humanized NSG-β2m<sup>-/-</sup> Model for Investigation of Immune and Anti-tumor Effects Mediated by the Bifunctional Immunotherapeutic Bintrafusp AlfaY Maurice Ii Morillon, Claire Smalley Rumfield, Samuel T Pellom, et al.
Current Pharmaceutical Design|February 4, 2006
TRICOM vector based cancer vaccinesCharlie T Garnett, John W Greiner, Kwong-Yok Tsang, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Bladder Cancer (Amsterdam, Netherlands)|November 13, 2018
Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder CancerMolly A Ingersoll, Xue Li, Brant A Inman, et al.
Cancer Research|May 20, 2004
Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN miceHasan E Zeytin, Arti C Patel, Connie J Rogers, et al.
Vaccine|August 19, 2008
Exercise enhances vaccine-induced antigen-specific T cell responsesConnie J Rogers, David A Zaharoff, Kenneth W Hance, et al.
Oncotarget|April 1, 2014
The immunocytokine NHS-IL12 as a potential cancer therapeuticJonathan Fallon, Robert Tighe, Giorgio Kradjian, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2014
Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasisJo A Tucker, Caroline Jochems, Benjamin Boyerinas, et al.
The Journal of Nutrition|December 25, 2007
Energy restriction and exercise differentially enhance components of systemic and mucosal immunity in miceConnie J Rogers, David Berrigan, David A Zaharoff, et al.
Cancer Research|September 5, 2002
Carcinoembryonic antigen as a target for specific antitumor immunotherapy of head and neck cancerErik S Kass, John W Greiner, Judith A Kantor, et al.
Advances in Cancer Research|June 4, 2014
Therapeutic cancer vaccinesJeffrey Schlom, James W Hodge, Claudia Palena, et al.
Frontiers in Oncology|May 7, 2020
The Use of a Humanized NSG-β2m<sup>-/-</sup> Model for Investigation of Immune and Anti-tumor Effects Mediated by the Bifunctional Immunotherapeutic Bintrafusp AlfaY Maurice Ii Morillon, Claire Smalley Rumfield, Samuel T Pellom, et al.
Current Pharmaceutical Design|February 4, 2006
TRICOM vector based cancer vaccinesCharlie T Garnett, John W Greiner, Kwong-Yok Tsang, et al.
Pageof 4